InSysBio to present Heta compiler version 0.6

NEWS
Press-Release
April 6, 2021

April 6, 2021

InSysBio presents the major updates of Heta compiler. Heta compiler is a software tool for development of QSP modeling platforms. In fact, its core option is the compilation of Heta-based platforms.
Its functionality has been significantly elaborated and now Heta compiler has become even more useful and functional. The list of the introduced features:

  • units consistency checking in mathematical expressions is implemented
  • creation of several models in the framework of single QSP platform and an option to export them to different modeling tools is maintained
  • “events” system describing discrete changes in a dynamic model is modified
  • the new version of Heta compiler follows the Heta standard 0.4

To learn more about Heta compiler, please visit https://hetalang.github.io/

About Heta

Heta project is an initiative for the development of infrastructure for modeling in pharmacology and systems biology. The project also summarizes our experience in modeling of dynamical systems: systems biology, PK/PD, QSP as well as best practices of software development.

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

June 2025
MoTuWeThFrSaSu
      
1
2
3
1. 03 Jun 2025 20:43 InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling InSysBio releases an integration of CYTOCON DB and fIVE DB with Heta. Now Heta format is upgraded to allow direct query to databases from the QSP model code without working with database websites.
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
1. 18 Jun 2025 18:30 InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology The new article “Quantitative Systems Pharmacology Model That Describes Neurofilament Light Dynamics During Alzheimer's Disease Progression” by Polina Maliukova, Tatiana Karelina was published in CPT: Pharmacometrics & Systems Pharmacology Journal on June 17, 2025
19
20
21
22
23
24
25
1. 25 Jun 2025 14:32 The project aims at translational mechanistic modeling of antibodies to predict human pharmacokinetics and target occupancy in cerebrospinal fluid InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the extension of collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer’s Disease.
26
27
28
29
30
      
Upcoming Events
Tags
Latest News
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling
30.05
InSysBio to publish the new article in CPT: Clinical Pharmacology & Therapeutics
15.05
15th InSysBio’s Annual Internal Scientific Meeting